IOMED will participate as a sponsor at the 14th Annual Outsourcing in Clinical Trials Europe 2024 (OCTEU), event where pharmaceutical and biotechnological leaders can find solutions to current challenges, taking place on May 7th and 8th in Barcelona.
Today, the European Parliament has taken a monumental step towards a stronger European Health Union with the adoption of the European Health Data Space (EHDS).
The journey has been developed around three round tables: how will be the hospital of the future, clinical studies in the framework of a European proposal and the secondary use of data for research and artificial intelligence.
4YFN celebrates its tenth edition this year and one of the novelties is the incorporation of a new pavilion dedicated to the health sector.
Artificial Intelligence enables the acceleration of patient recruitment processes and the reduction of research timelines.
This distinguished label is bestowed upon companies showcasing an outstanding level of innovation in their initiatives, as acknowledged by the European Commission.
The CB Insights Digital Health 50 of 2023 honorees were selected from a pool of more than 10,000 companies
The Artificial Intelligence company IOMED has launched several training sessions in healthcare centres such as the Hospital Universitario Fundación Alcorcón (Madrid) and the Hospital de Sant Pau (Barcelona).
IOMED's co-founder and CTO Gabriel Maeztu gave an engaging workshop at PyDay BCN held at the University of Barcelona on 11 November.
In just six years, IOMED has become a leading company in Artificial Intelligence in healthcare, with a nationwide presence and ongoing expansion into European countries.
Philips Ventures -the venture capital group of health technology leader Philips- and XTX Ventures -the venture capital arm of leading algorithmic trading company XTX Markets-, led the latest funding round of IOMED. Fondo Bolsa Social and Redseed also participated in the round, as well as IOMED’s existing investors Adara Ventures and EASO Ventures.
The tech team has collaborated with the research group at HITZ to create an annotated corpus of medical sections.
Artificial intelligence will allow the Clinic to analyze millions of clinical data in one-tenth of the time it takes for manual processes.
IOMED's technology significantly reduces the time required for obtaining clinical research data.
The Cantabrian Health Service (SCS) will be the first in Spain to fully embrace artificial intelligence (AI), developed by IOMED Medical Solutions, to structure electronic health records (EHR) across its entire healthcare system.
Join our newsletter to receive updates and news about the sector
.svg)
.png)
.jpg)
